148159 -OEChem-03010813452D 7 0 0 0 0 0 0 0 0999 V2000 -0.0250 1.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 0.5000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 0.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -0.5000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -1.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -1.5000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -2.0000 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 A 1 R A 2 R A 3 R A 4 R A 5 R A 6 R A 7 R M END > 0 > 0 > 148159 > 1 > DTP/NCI > 300901 > Development Therapeutics Program NCI/NIH > 0.54 mg 1, 2,5,8-tetrahydroxyanthraquinone 0.54 mg 2,5-dihydroxy p-quinone 0.90 mg croconic acid 1.62 mg catechol 1.81 mg croconic acid polymer 2.0 mg p-tert. butyl catechol 2.70 mg tetrahydroxyquinone 5.43 mg tetrahydroxyquinone polymer Composition for every 1.0 ml H(2)O : 13.5 mg sodium sulfite KOH to pH 9.5-10.0 NSC300901 > NSC300901 > http://dtp.nci.nih.gov/ > http://dtp.nci.nih.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=300901 $$$$